Medical Distributors Stocks Fall After Opioid Data Reports

Wednesday’s decline puts a pause on solid performance for medical distributors like AmerisourceBergen, which has gained 14.8% in 2019.


Kristoffer Tripplaar/Sipa USA/Associated Press

Shares of medical distributors and other health-care companies took a hit on Wednesday, and their pain may not be short-lived.


fell 4%, while Cardinal Health, Inc. shed 3.8%.


lost about 2.7% in recent trading. All three performed worse than the broader U.S. stock market on Wednesday, which recorded small declines.

Their declines come after news reports revealed new government data on information about opioid sales and distribution before 2013.

Wednesday’s drop puts a pause on solid performance for the medical distributors so far this year.

AmerisourceBergen has gained 14.8% in 2019, while McKesson is up 26%. Cardinal has edged higher about 1% this year.

Other pharmaceutical companies have also had a rough week.

CVS Health


Walgreens Boots Alliance

simultaneously fell on Wednesday.

Morgan Stanley

downgraded pharmaceutical companies

Teva Pharmaceutical Industries


Endo International

PLC to “underweight” earlier this week, saying that they are exposed to opioid litigation. Teva lost 6.3% on Wednesday while Endo fell about 3.1%. Shares of both have lost more than 50% this year.

“Opioid litigation is just getting started. There are thousands of lawsuits, and we see the potential for negative litigation developments over the next few years,” wrote Morgan Stanley analysts in a note on Monday.

Write to Gunjan Banerji at

Copyright ©2019 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

error: Content is protected !!